AMBER ABRAMS: Open Payments
NPI 1487036950 · PARKER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$522 in 23 payments from 10 companies in 2025. Trend: 2023 $569 · 2024 $731 · 2025 $522
Food & beverage: $522
| Company | Payments | Amount |
|---|---|---|
| HEARTFLOW, INC. | 7 | $149 |
| Amgen Inc. | 3 | $64 |
| Novartis Pharmaceuticals Corporation | 2 | $57 |
| AstraZeneca Pharmaceuticals LP | 2 | $53 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $48 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $42 |
| Novo Nordisk Inc | 1 | $31 |
| E.R. Squibb & Sons, L.L.C. | 1 | $18 |
| SCPHARMACEUTICALS INC. | 1 | $15 |
Products named: FFRct, REPATHA, WAINUA, Kerendia, JARDIANCE, VYNDAQEL, LEQVIO, Wegovy.
Industry payments across CO — which companies pay providers there.
